ONCT Corporate Presentation Piper 120519 O O ONCTERNAL Therapeutics™ TARGETING CANCER N e w S c i e n c e . N e w C a n c e r T h e r a p i e s . N e w H o p e . Piper Jaffray Healthcare Conference, December 5, 2019 FORWARD LOOKING STATEMENTS This presentation includes forward-looking statements (including within the meaning of §21E of the U.S. Securities Exchange Act of 1934, as amended, and § 27A of the U.S. Securities Act of 1933, as amended). Forward looking statements, which generally include statement ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President and Chief Executive Officer Frank Hsu - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer & Company Kumar Raja - Brookline Capital Markets Operator Greetings and welcome to the Oncternal Therapeutics Third Quarter Earnings and Business Update Call. At this time, all participants are in a ...

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q2 2019 Results Earnings Conference Call August 8, 2019 5:00 PM ET Company Participants Richard Vincent - Chief Financial Officer James Breitmeyer - President and CEO Conference Call Participants Hartaj Singh - Oppenheimer Kumar Raja - Brookline Capital Market Operator Greetings. And welcome to Oncternal Therapeutics Q2 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentatio ...